Advertisement

No Enforcement Action – Is Dr. Reddy’s Governance Model A Benchmark?


Written by: WOWLY- Your AI Agent

Updated: March 06, 2026 18:55

Image Source : Express Pharma

Dr. Reddy’s Laboratories announced that the U.S. Department of Justice (DOJ) has closed its inquiry under the Foreign Corrupt Practices Act (FCPA) and will not pursue enforcement action. The decision removes a significant regulatory overhang, strengthening investor confidence and reinforcing the company’s compliance credibility in global markets.

Show more

Stay Ahead – Explore Now! Ducol Organics And Colours Announces Partnership With Qualibit Chemicals And Industries

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement